- 前沿生物 (688221)- 融资性负债

  1. 首 页
  2. 前沿生物
  3. 融资性负债

按负债来源分类：发行债券或借贷而来的融资性负债分析

归母股东权益
11.5亿    ,5.0,6.4,6.0,21.4,18.3,16.7,13.4,11.5
了解明细
少数股东权益
0亿    ,0,0.0,0.0,-0.0,0,0,0,0
了解明细
负债合计
8.6亿    ,0.6,0.9,3.4,3.8,7.0,7.4,8.0,8.6
了解明细
资产合计
20.1亿    ,5.7,7.2,9.4,25.2,25.3,24.1,21.4,20.1
了解明细



融资性负债
4.5亿    ,0.1,0.1,0.4,0.4,3.0,2.9,3.9,4.5
22.4%
了解明细
经营性负债
4.1亿    ,0.5,0.8,3.0,3.4,4.0,4.5,4.1,4.1
20.4%
了解明细
分配性负债
0.0亿    ,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
0%
了解明细



短期借款
2.9亿    ,0.1,0.0,0.1,0.1,0.5,1.1,2.0,2.9
了解明细
一年内到期的非流动负债
1.0亿    ,0.0,0.0,0.1,0.1,2.4,0.6,1.1,1.0
了解明细
长期借款
0.5亿    ,0,0,0.2,0.1,0.1,1.2,0.7,0.5
了解明细
应付债券
0亿    ,0,0,0,0,0,0,0,0
了解明细
应付利息
0.0亿    ,0,0,0,0.0,0.0,0.0,0.0,0.0
了解明细
交易性金融负债
0亿    ,0,0,0,0,0,0,0,0
了解明细
衍生金融负债
0亿    ,0,0,0,0,0,0,0,0
了解明细
资产负债表排雷 资产成长性分析 资产营运能力分析 资产质量分析 财务安全分析

通过 前沿生物 负债的来源分类：一类为融资性负债，是企业因运营或投资需要，发行债券或借贷而产生的负债；一类为分配性负债，是因为企业利润而产生， 应付但未付的所得税和股利；一类为经营性负债，是因经营活动产生的负债。